StockData
Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc. (ARCT) stock

ARCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/309% below fair value
$7.60−0.44 (-5.47%)

Close on Nov 19, 2026Market cap $216.02MP/E –Yield –

Arcturus Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Arcturus Therapeutics

Arcturus Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Arcturus Therapeutics figures

See a number that looks wrong?